2[1]Brandes A,Ernani M,Basso U,et al.Temozolomide as a secondline systemic regimen in recurrent highgrade glioma:a phase Ⅱ study[J].Ann Oncol,2001,12(2):255～257. 被引量：1
3[2]Stupp R,Dietrich PY,Ostermann Kraljevic S,et al.Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide[J].J Clin Oncol,2002,20(5):1 375～1382. 被引量：1
4[3]Yung WK,Albright RE,Olson J,et al.A phase Ⅱ study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse[J].Br J Cancer,2000,83(5):588～593. 被引量：1
5[7]Chinot O.Chemottherapy for the treatment of oligodendroglial tumors[J].Semin Oncol,2001,28(4 suppl 13):13～18. 被引量：1
6Brandes AA,Ermani M,Basso U,et al.Temozolomide as a secondline systemic regimen in recurrent high-grade glioma:a phase Ⅱ study[J].Ann Oneol,2001,12:255. 被引量：1
7Stupp R,Dietrich PY,Ostermann Kraljevic S,et al.Promising survival for patients with newly diagnosed gliolastoma multiformetreated with concomitant radiation plus temozolomiede followed by adjuvant temozolomide[J].J Clin Oncol,2002, 20:1375. 被引量：1
